| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
4-phenylnaphthalen-1-ylboronic acid
|
372521-91-0 |
(1-苯基萘-4-基)硼酸
|
4-苯基萘-1-硼酸;(1-苯基萘-4-基)硼酸;4-苯基萘-1-硼酸 (含不同量的酸酐);(4-苯基萘基-1-基)硼酸;4-苯基-1-萘硼酸 1G;4-苯基萘-1-基硼酸;1-(4-苯基萘)硼酸
|
C16H13BO2 |
248.084 | |
|
1-CHLOROETHYLTRIMETHYLSILANE
|
7787-87-3 |
(1-氯乙基)三甲基硅烷
|
(1-氯乙基)三甲基硅烷
|
C5H13ClSi |
136.7 | 232-135-8 |
|
(+(-TAXIFOLIN
|
17654-26-1 |
(2R,3R)-二氢槲皮素
|
(+)-花旗松素标准品
|
C15H12O7 |
304.25 | 207-543-4 |
|
Benzyl (2R,3S)-(1-carbamoyl-2-hydroxypropyl)carbamate
|
49705-98-8 |
(2R,3S)-(1-氨基甲酰基-2-羟基丙基)氨基甲酸苄酯
|
CBZ-THR-NH2;(2R,3S)-(1-氨基甲酰基-2-羟基丙基)氨基甲酸苄酯;N-苄氧羰基-L-苏胺酰胺;CBZ-苏氨酰胺;CBZ-L-苏氨酰胺((2R,3S)-(1-氨基甲酰基-2-羟基丙基)氨基甲酸苄酯);Z-L-苏氨酰胺
|
C12H16N2O4 |
252.26644 | 256-436-9 |
|
Argatroban Impurity 24
|
74874-10-5 |
(2R,4R)-1-[(2S)-5-[[亚硝胺甲基]氨基]-2-[[(3-甲基-8-喹啉基)酰磺基]氨基]-1-氧代戊基]-4-甲基-2-哌啶甲酸
|
(2R,4R)-1-[(2S)-5-[[亚硝胺甲基]氨基]-2-[[(3-甲基-8-喹啉基)酰磺基]氨基]-1-氧代戊基]-4-甲基-2-哌啶甲酸;(2R,4R)-1-[(2S)-5-[[亚氨基(硝基氨基)甲基]氨基]-2-[[(3-甲基-8-喹啉基)磺酰基]氨基]-1-氧代戊基]-4-甲基-2-哌啶甲酸;阿加曲班-6;阿加曲班杂质24
|
C23H31N7O7S |
549.6 | |
|
(2S,3S)-2-Chloro-3-methylvaleric Acid
|
32653-34-2 |
(2S,3S)-2-氯-3-甲基戊酸
|
(2S,3S)-2-氯-3-甲基戊酸;(2S,3S)-2-氯-3甲基-正缬酸;(2S,3S)-2-氯-3-甲基戊酸
|
C6H11O2Cl |
150.60334 | |
|
(2S,3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride
|
944716-73-8 |
(2S,3S)-3-氨基-N-环丙基-2-羟基己酰胺盐酸盐
|
(2S,3S)-3-氨基-N-环丙基-2-羟基己酰胺盐酸盐;特拉匹韦中间体4;3、944716-73-8 (2S,3S)-3-氨基-N-环丙基-2-羟基己酰胺盐酸盐
|
C9H18N2O2.HCl |
222.71236 | 619-041-6 |
|
(2-BROMOETHYL)TRIMETHYLSILANE
|
18156-67-7 |
(2-溴乙基)三甲基硅烷
|
2-(TRIMETHYLSILYL)ETHYL BROMIDE;(2-BROMOETHYL)TRIMETHYLSILANE;(2-Bromoethyl)trimethylsilane (stabilized with NaHCO3);(2-BroMoethyl)triMethylsilane (stabilized with NaHCO3);(2-Bromoethyl)trimethylsilane (stabilized with Silver chip);(2-Bromoethyl)trimethylsilane ;(stabilized with NaHCO3)
|
C5H13BrSi |
181.15 | |
|
DIMETHYL (2-OXOHEPTYL)PHOSPHONATE
|
36969-89-8 |
(2-氧代庚基)膦酸二甲酯
|
(2-氧代庚基)膦酸二甲酯;2-氧庚基膦酸二甲酯;(2-氧代庚基)磷酸二甲酯;地诺前列素中间体;前列地尔中间体
|
C9H19O4P |
222.22 | 253-293-4 |
|
(R)-3-Aminoazepan-2-one Hydrochloride
|
26081-03-8 |
(3R)-3-氨基六氢-2H-氮杂卓-2-酮单盐酸盐
|
D (-)-ALPHA-AMINO-EPSILON-CAPROLACTAM HYDROCHLORIDE;(R)-3-AMINOAZEPAN-2-ONE HYDROCHLORIDE;2H-Azepin-2-one, 3-aminohexahydro-, hydrochloride (1:1), (3R)-;D-AMino caprolactaM HCL SALT;R-3-AMinohexahydro-2H-azepin-2-one hydrochloride;(3R)-3-Aminohexahydro-2H-azepin-2-one monohydrochloride
|
C6H12N2O.ClH |
164.63 | |
|
(3R,5R)-(-)-3,5-HEPTANEDIOL
|
77291-90-8 |
(3R,5R)-(-)-3,5-庚烷二醇
|
(3R,5R)-(-)-3,5-庚烷二醇;(3R,5R)-3,5-庚二醇
|
C7H16O2 |
132.20074 | |
|
Simvastatin hydroxy Acid Ammonium Salt
|
139893-43-9 |
(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-(2,2-二甲基丁酰氧基)-1,2,6,7,8,8a-六氢-2,6-二甲基-1-萘基]-3,5-二羟基庚酸铵
|
辛伐他汀开环铵盐;辛伐他汀乙酸铵盐;辛伐他汀羟酸铵盐;辛伐他汀酸铵盐;SIMV-IM B;辛伐他汀羟基酸铵盐;(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-(2,2-二甲基丁酰氧基)-1,2,6,7,8,8a-六氢-2,6-二甲基-1-萘基]-3,5-二羟基庚酸铵;辛伐他汀铵盐
|
C25H39O6-.H4N+ |
453.61202 | 1533716-785-6 |
|
Rosuvastatin EP Impurity G (Calcium Salt)
|
1242184-42-4 |
(3S,5R)-瑞舒伐他汀
|
瑞舒伐他汀钙EP杂质G(3S5R);(3S,5R)-瑞舒伐他汀;ROSUVASTATIN CALCIUM-8;瑞舒伐他汀杂质G;瑞舒伐他汀钙EP杂质G;瑞舒伐他汀EP杂质G;EP杂质G;瑞舒伐他汀EP杂质G(钙盐)
|
C22H28FN3O6S |
481.5376232 | |
|
Diethyl 3-methoxybenzylphosphonate
|
60815-18-1 |
(3-甲氧苄基)膦酸二乙酯
|
(3-甲氧苄基)膦酸二乙酯;(3-甲氧基苄基)膦酸二乙酯;间甲氧基苄基磷酸二乙酯;3-甲氧基苄基磷酸二乙酯;二乙基(3-甲氧基苄基)膦酸酯
|
C12H19O4P |
258.25 | |
|
(3-Bromopropyl)triphenylphosphonium Bromide
|
3607-17-8 |
(3-溴丙基)三苯基溴化磷
|
(3-溴丙基)三苯基溴化L;(3-溴丙基)三苯基溴化膦,98%;3-溴丙基溴化三苯磷;(3-溴丙基)三苯基溴化磷鎓;(3-溴丙基)三苯基溴化鏻;(3-溴丙基)三苯基溴化;(3-溴丙基)三苯基溴化磷;(3-溴丙基)三苯基溴化膦
|
C21H21Br2P |
464.17 | 222-770-9 |
|
(3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER
|
58885-60-2 |
(3-氧代丙基)氨基甲酸叔丁酯
|
(3-氧代丙基)氨基甲酸叔丁酯;3-(BOC-氨基)丙醛;N-(3-氧代丙基)氨基甲酸叔丁酯
|
C8H15NO3 |
173.21 | |
|
Ethyl 2-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
|
859169-20-3 |
(4-乙氧羰基甲苯基)硼酸片钠醇酯
|
(4-乙氧羰基甲苯基)硼酸片钠醇酯;(4-乙氧羰基甲苯基)硼酸频哪醇酯;(4-乙氧羰基甲苯基)硼酸片钠醇酯 5G;(4-乙氧羰基甲苯基)硼酸嚬哪醇酯;(4-乙氧羰基甲苯基)硼酸频钠醇酯;4-乙酸乙酯苯硼酸频哪醇酯;(4-乙氧羰基甲苯基);硼酸片钠醇酯
|
C16H23BO4 |
290.165 | |
|
(5R)-5-(2,2-Dimethyl-4H-1,3-Benzodioxin-6-yl)-1,3-oxazolidin-2-one
|
452339-73-0 |
(5R)-5-(2,2-二甲基-4H-1,3-苯并二恶英-6-基)-1,3-恶唑烷-2-酮
|
(5R)-5-(2,2-二甲基-4H-1,3-苯并二恶英-6-基)-1,3-恶唑烷-2-酮;BNKY020-VT04;2-恶唑烷酮,5-(2,3-苯并二氧-6-YL),(5R)-;(R)-5-(2,2-DIMETHYL-4H-BENZO[D][1,3]DIOXIN-6-YL)OXAZOLIDIN-2-ONE;(5R)-5-(2,3-苯并二氧杂环己-6-基)-1,3-恶唑烷-2-酮;2-恶唑烷酮,3-苯并二氧-6-YL);(R)-5-(2,2-二甲基-4H-苯并[D][1,3]二氧杂环己烯-6-基)恶唑烷-2-酮;维兰特罗关键中间体
|
C13H15NO4 |
249.27 | 1592732-453-0 |
|
(9b,11b,16a)-9,11-Epoxy-21-hydroxy-16-methylpregna-1,4-diene-3,20-dione
|
151265-33-7 |
(9B,11B,16A)-9,11-环氧-21-羟基-16-甲基孕-1,4-二烯-3,20-二酮
|
(9B,11B,16A)-9,11-环氧-21-羟基-16-甲基孕-1,4-二烯-3,20-二酮;17-去羟氧化物
|
C22H28O4 |
356.45532 | |
|
(BPEF) (Bis (2-Phenoxy Ethanol)Fluorene)
|
117344-32-8 |
(BPEF)(双(2-苯氧基乙醇)氟)
|
9,9 –二(2-羟基乙氧基)苯基)芴;双醚芴,9 –二(2-羟基乙氧基)苯基)芴;9,9-双[4-(2-羟乙氧基)苯基]芴,98%;4′-(9-亚芴基)二(2-苯氧乙醇);9,9-二[(4-羟乙氧基)苯基]芴 500G;9,9-二[(4-羟乙氧基)苯基]-9H-芴;9,9-双[(4-(2-羟乙氧基)苯基]芴;9,9-二[(4-羟乙氧基)苯基]芴
|
C29H26O4 |
438.51 | 672-704-1 |
药智官方微信
药智官方微博
